Digital Health Startups

NeuroQore develops neuromodulation treatments for neurobehavioral conditions, focusing on treatment-resistant major depressive disorder and suicidality. It works with universities and research clinics to investigate new interventions as alternatives to existing treatments like rTMS and ECT.

1 investor

NeuroSigma is a bioelectronic medical device company that makes non-invasive external trigeminal-nerve stimulation systems to treat chronic neurological and neuropsychiatric disorders. Its Monarch eTNS System is an FDA-cleared, prescription home-use device for treating pediatric ADHD in children ages 7 to 12, with additional programs targeting conditions such as autism spectrum disorder, epilepsy, and depression.</parameter> <parameter name="founders">[]

1 investor

NeuroSmart develops technology that enables users to treat stress as a trainable skill through neuroscience-based approaches. The company is focused on digital health and behavioral wellness applications.

1 investor

NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS. Its lead candidate, NTRX-07, is a CB2 receptor agonist designed to reduce neuroinflammation and promote neuronal survival.

1 investor

Neurotone develops auditory training software for hearing loss patients. The platform helps patients improve hearing comprehension through brain-based learning, built on over 20 years of clinical research in hearing care.

1 investor

NeuroTx develops AI-powered electroceutical and neurotechnology solutions that use neural decoding and non-invasive vagus nerve stimulation to support sleep quality, cognitive function, and metabolic health. The company integrates wearable devices, mobile applications, and machine learning to deliver personalized bio-signal-based interventions for consumers and patients.

1 investor

Neurotype provides AI software that helps clinicians convert multi-source case evidence (interviews, developmental histories, questionnaires, school input, GP letters, assessment notes) into structured, clinic-formatted draft diagnostic reports for ADHD and autism assessments, with the clinician retaining responsibility for judgment and sign-off. It targets neurodevelopmental diagnostic clinics across the UK and Ireland, aiming to cut report-writing time and increase assessment capacity.

1 investor

NeuroVirt provides mixed reality therapy software for stroke and neurorehabilitation, offering gamified exercises for upper and lower limb recovery in clinical and home settings with real-time motion tracking and clinician dashboards.

1 investor

NeuroZen develops AI-based neuroimaging and genetic tools to predict, quantify, and monitor Alzheimer's disease and neurodegeneration, using multimodal clinical, neuropsychological, MRI, PET, and genomic data. Its products include AlzgenAI (genomic risk prediction), MemoAI (tablet-based cognitive testing), and NeuroAI (MRI/APOE-based amyloid PET positivity prediction), aimed at physicians for clinical decision-making, with a focus on Korean and Asian dementia cohorts.

1 investor

An independent nonprofit academic research institution that convenes talent from academic, research, and medical institutions to advance collaborative genomic research and accelerate discoveries in the genetic basis of disease for clinical diagnosis and treatment.

1 investor

Health Law Advisor is a legal blog published by law firm Epstein Becker Green that covers regulatory, enforcement, and litigation developments affecting the health care and life sciences industries. It analyzes topics such as federal fraud enforcement, Medicare/Medicaid rules, and health-related court decisions for providers, health systems, and industry stakeholders.

1 investor

New Day Healthcare invests in home care and hospice businesses, providing capital and operational expertise from seasoned industry leaders to support patient-centered outcomes. The firm partners with home care operators who share its values of clinical quality, financial responsibility, and mission-driven stewardship.

1 investor

NewGen Health is developing an at-home care management platform, including a SmartCup device that analyzes urine samples and vital signs at home, with results and trends shared with patients' care teams via cloud storage and EMR integration. It targets monitoring for chronic kidney disease, expectant mothers, and diabetes/cardio-metabolic care, with a stated focus on health equity and accessible care.

1 investor

Newmi is a women's health platform in India that combines virtual consultations, in-clinic visits, diagnostics, pharmacy and preventive care across life stages from puberty to menopause. It also offers women-focused outpatient care as a corporate benefit for employers, insurers, and brokers.

1 investor

Newronika is a spin-off of Italian research institutions Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and the University of Milan that develops adaptive deep brain stimulation (αDBS) technology which responds to brain activity in real time. Its neuromodulation systems target Parkinson's disease and are being studied for a broader range of brain disorders, serving clinicians and patients.

1 investor

Newself connects individuals with therapists through an AI-powered platform that helps clients track emotions and patterns while providing therapists with insights to streamline care delivery. The company targets both patients and mental health professionals seeking more connected, efficient therapy experiences.

1 investor

Newton is an innovation company that develops therapeutic optical lenses for treating eye-related conditions like headaches, motion sickness, and neck pain caused by eye misalignment. The company serves optometrists and patients across North America and Europe in the healthcare and optical devices sector.

1 investor

Nexkin Medical designs and manufactures medical devices and systems for allergology testing. The company develops patient-centric digital health solutions aimed at improving allergy diagnosis and management.

1 investor

Nexmedis offers an AI-powered Health Information System (HIS) for medical facilities, including clinical decision support that suggests differential diagnoses and real-time patient data access. It also transcribes doctor-patient consultations in real time and organizes them into the SOAP framework.

1 investor

NEXOD develops dental CAD/CAM products for chairside dentistry, including the NEXOD M1 milling machine and the COMFORT+ intraoral scanner, along with a digital workflow system for one-day dental treatments. The company's products are manufactured in Korea and target dental practices.

1 investor

A biotechnology company developing patent-pending technology to combat antibiotic resistance by targeting bacterial resistance mechanisms and restoring the effectiveness of existing antibiotics.

1 investor

NextCare operates urgent care and occupational medical clinics across 12 US states, providing accessible healthcare services through multiple brands. The company manages over 150 clinical locations serving patients needing non-emergency medical care.

1 investor

NextGen Jane runs a longitudinal molecular study of women's menstruation, using an at-home organic cotton tampon collection kit that members mail in to derive genomic insights from uterine samples. The company aims to improve diagnostics and treatment for gynecological conditions such as endometriosis and other menstrual and reproductive health issues.

1 investor

Nexus develops healthcare software solutions for hospitals, rehabilitation facilities, specialist clinics, and nursing homes, with a focus on sustainability and ESG principles. The company optimizes software for energy efficiency and process improvement to free up clinical staff for patient care.

1 investor